anthralin


Also found in: Encyclopedia.

anthralin

 [an´thrah-lin]
an anthraquinone used topically in treatment of psoriasis.

anthralin

/an·thra·lin/ (an´thrah-lin) an anthraquinone derivative used topically in psoriasis.

anthralin

[an′thrəlin]
a topical antipsoriatic.
indications It is prescribed in the treatment of psoriasis and chronic dermatitis.
contraindications Known hypersensitivity to this drug prohibits its use. It is not applied to acute psoriatic eruptions or near the eyes.

anthralin

(an′thră-lĭn) [ anthr(acene) + -al + -in]
A synthetic hydrocarbon refined from anthracine. It is used in ointment form for treating various skin diseases (e.g., fungal infections and eczema).
References in periodicals archive ?
Anthralin was first taken from tree bark and found to effectively treat psoriasis, while topical nitrogen mustard has been used since 1959 for cutaneous T-cell lymphomas.
We believe anthralin works in an immunomodulatory fashion," Dr.
Inhibition of human monocyte functions by anthralin.
Casaccio treats her psoriasis with light therapy, anthralin and coal tar baths with the occasional use of topical steroids and Tazorac (tazarotene), a synthetic form of vitamin A.
Zithranol[TM]-RR provides an advanced delivery system for anthralin achieving long remission times with no long-term side effects in a steroid-free, silky cream.
and Canadian marketing rights to Micanol(TM) (anthralin) cream 1%, Bioglan's patented topical anthralin product for the treatment of psoriasis.
Treatment includes topical corticosteroids, anthralin (Anthra-Derm, Lasan), and ultraviolet light.
In addition, anthralin cream or ointment, a synthetic, tar-like substance often used for psoriasis, can be applied once a day to bare patches of skin, with new hair growth possibly occurring in eight to 12 weeks.
Anthralin has been used topically to treat psoriasis for at least 75 years and is regarded as a safe and effective treatment with one of the longest remission rates for any psoriasis medication.
Blended NovasomeR vesicles are particularly important in making cosmetically acceptable and stable preparations of water- immiscible material such as retinoic acid, its derivatives, and anthralin.
The studies, which involved 51 patients, showed that IGI's NOVASOME- encapsulated anthralin was preferred by patients in side-by-side testing against Anthraderm.
IGI presented human pre-FDA clinical data from the Psoriasis Research Institute in Palo Alto showing superior results and cosmetic preference with anthralin encapsulated in Novasomes.